Alcohol and Substance Abuse in Solid-Organ Transplant Recipients

被引:49
|
作者
Parker, Richard [1 ,2 ,3 ]
Armstrong, Matthew J. [1 ,2 ,3 ]
Corbett, Chris [1 ,2 ,3 ]
Day, Edward J. [4 ]
Neuberger, James M. [3 ,5 ]
机构
[1] Univ Birmingham, Natl Inst Hlth Res Biomed Res Unit, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
[4] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
[5] NHS Blood & Transplant, Bristol, Avon, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Alcohol; Drugs; Substance abuse; Transplantation; ORTHOTOPIC LIVER-TRANSPLANTATION; CARBOHYDRATE-DEFICIENT TRANSFERRIN; LONG-TERM GRAFT; ETHYL GLUCURONIDE; FOLLOW-UP; PSYCHOSOCIAL EVALUATION; INTERNATIONAL-SOCIETY; HEART-TRANSPLANTATION; LABORATORY MARKERS; SCREENING-TEST;
D O I
10.1097/TP.0b013e31829f7579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review focuses on alcohol and substance abuse in the context of solid-organ transplantation. Alcohol and substance abuse are common and may lead to a need for solid-organ transplantation and may also contribute to significant physical and psychologic problems that impact upon the recipient. Damaging levels of alcohol intake can occur in the absence of dependence. Alcohol or substance abuse after transplantation is associated with poor medication compliance and this may increase risk of graft loss. Intravenous drug use is associated with increased risk of infections (especially secondary to opportunistic organisms-bacterial, viral, protozoal, and others-and such infections may be more severe in the immunosuppressed), but there is only anecdotal evidence that such behavior has a worse outcome in transplant recipients. Whereas previous alcohol excess and drug use in kidney recipients are both associated with a small but statistically significantly increased risk of adverse outcomes (hazard ratio, 1.16-1.56), alcohol use within recommended guidelines after transplantation appears safe and possibly beneficial. Robust data are lacking for other organs, but those available suggest that heart transplantation is safe in individuals with a history of alcohol or substance abuse. Health specialists in drug or alcohol addiction should carefully screen all potential transplant candidates for these conditions, and where there is evidence of dependency or abuse, effective psychologic and physical treatment should be offered. Studies have shown that interventions such as psychologic intervention have improved alcohol behavior in the context of liver transplantation. Although there are no comparable studies with other solid-organ recipients, it is reasonable to expect transferable outcomes.
引用
收藏
页码:1015 / 1024
页数:10
相关论文
共 50 条
  • [31] Candida in Solid Organ Transplant Recipients
    Pappas, P. G.
    Silveira, F. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : S173 - S179
  • [32] Blastomycosis in solid organ transplant recipients
    Gauthier, G. M.
    Safdar, N.
    Klein, B. S.
    Andes, D. R.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (04) : 310 - 317
  • [33] Chromoblastomycosis in Solid Organ Transplant Recipients
    Kumbhakar, Raaka
    Miko, Benjamin A.
    CURRENT FUNGAL INFECTION REPORTS, 2019, 13 (04) : 139 - 145
  • [34] Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients
    Kamar, Nassim
    Weclawiak, Hugo
    Guilbeau-Frugier, Celine
    Legrand-Abravanel, Florence
    Cointault, Olivier
    Ribes, David
    Esposito, Laure
    Cardeau-Desangles, Isabelle
    Guitard, Joelle
    Sallusto, Federico
    Muscari, Fabrice
    Peron, Jean Marie
    Alric, Laurent
    Izopet, Jacques
    Rostaing, Lionel
    TRANSPLANTATION, 2012, 93 (06) : 617 - 623
  • [35] A New Routine Immunity Score (RIS2020) to Predict Severe Infection in Solid-Organ Transplant Recipients
    Sarmiento, Elizabeth
    Ezzahouri, Ikram
    Jimenez-Lopez, Maricela
    Carre, Kristofer M. Limay
    Alonso, Rocio
    Ortiz-Bautista, Carlos
    Plaza, Magdalena Salcedo
    Rodriguez-Ferrero, Maria Luisa
    Padilla-Machaca, Pedro Martin
    Cerron, Ana
    Chaman, Jose Carlos
    Salvo, Ana P. Vionnet
    Carbone, Javier
    ANNALS OF TRANSPLANTATION, 2025, 30
  • [36] Cardiovascular and renal complications in patients receiving a solid-organ transplant
    Diaz, Geraldine
    O'Connor, Michael
    CURRENT OPINION IN CRITICAL CARE, 2011, 17 (04) : 382 - 389
  • [37] Possible impact of immunosuppressive therapy regimens on histopathologic outcomes of abnormal uterine bleeding in solid-organ transplant recipients
    Tohma, Yusuf Aytac
    Akilli, Huseyin
    Kirnap, Mahir
    Haberal, Asuman Nihan
    Akyel, Dilan
    Zengin, Hatice Yagmur
    Zeyneloglu, Hulusi Bulent
    Kuscu, Esra
    Ayhan, Ali
    Haberal, Mehmet
    CLINICAL TRANSPLANTATION, 2018, 32 (08)
  • [38] Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective
    Kowada, A.
    JOURNAL OF INFECTION, 2019, 78 (01) : 58 - 65
  • [39] Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients
    Diaz-Pedroche, Carmen
    Lumbreras, Carlos
    San Juan, Rafael
    Folgueira, Dolores
    Andres, Amado
    Delgado, Juan
    Meneu, Juan Carlos
    Morales, Jose Maria
    Moreno-Elola, Almudena
    Hernando, Susana
    Moreno-Gonzalez, Enrique
    Aguado, Jose Maria
    TRANSPLANTATION, 2006, 82 (01) : 30 - 35
  • [40] Micafungin for therapy of invasive candidiasis in solid organ transplant recipients
    Fortun-Abete, Jesus
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2009, 26 (01): : 65 - 68